Theoretical and experimental approaches aimed at drug design targeting neurodegenerative diseases
dc.contributor.author | Morales-Navarro, Samuel | |
dc.contributor.author | Prent-Peñaloza, Luis | |
dc.contributor.author | Rodríguez Núñez, Yeray A. | |
dc.contributor.author | Sánchez-Aros, Laura | |
dc.contributor.author | Forero-Doria, Oscar | |
dc.contributor.author | González, Wendy | |
dc.contributor.author | Campilllo, Nuria E. | |
dc.contributor.author | Reyes-Parada, Miguel | |
dc.contributor.author | Martínez, Ana | |
dc.contributor.author | Ramírez, David | |
dc.date.accessioned | 2023-04-25T14:48:35Z | |
dc.date.available | 2023-04-25T14:48:35Z | |
dc.date.issued | 2019-12 | |
dc.description | Indexación: Scopus. | es |
dc.description.abstract | In recent years, green chemistry has been strengthening, showing how basic and applied sciences advance globally, protecting the environment and human health. A clear example of this evolution is the synergy that now exists between theoretical and computational methods to design new drugs in the most efficient possible way, using the minimum of reagents and obtaining the maximum yield. The development of compounds with potential therapeutic activity against multiple targets associated with neurodegenerative diseases/disorders (NDD) such as Alzheimer’s disease is a hot topic in medical chemistry, where different scientists from various disciplines collaborate to find safe, active, and effective drugs. NDD are a public health problem, affecting mainly the population over 60 years old. To generate significant progress in the pharmacological treatment of NDD, it is necessary to employ different experimental strategies of green chemistry, medical chemistry, and molecular biology, coupled with computational and theoretical approaches such as molecular simulations and chemoinformatics, all framed in the rational drug design targeting NDD. Here, we review how green chemistry and computational approaches have been used to develop new compounds with the potential application against NDD, as well as the challenges and new directions of the drug development multidisciplinary process. | es |
dc.description.uri | https://www.mdpi.com/2227-9717/7/12/940 | |
dc.identifier.citation | Processes Volume 7, Issue 121 December 2019 Article number 940 | es |
dc.identifier.doi | DOI: 10.3390/PR7120940 | |
dc.identifier.issn | 2227-9717 | |
dc.identifier.uri | https://repositorio.unab.cl/xmlui/handle/ria/48905 | |
dc.language.iso | en | es |
dc.publisher | MDPI AG | es |
dc.rights.license | Atribution 4.0 International (CC BY 4.0) | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | |
dc.subject | Green Chemistry | es |
dc.subject | Drug Design | es |
dc.subject | Neurodegenerative Diseases | es |
dc.subject | Molecular Modeling | es |
dc.subject | Medical Chemistry | es |
dc.subject | Chemoinformatics | es |
dc.title | Theoretical and experimental approaches aimed at drug design targeting neurodegenerative diseases | es |
dc.type | Artículo | es |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Morales-Navarro_Theoretical_and_experimental_approaches_aimed.pdf
- Tamaño:
- 2.96 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- TEXTO COMPLETO EN INGLES
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: